Journal · Regenerative medicine · Updated 21 November 2026
Tissue Engineering and Regenerative Medicine
Read Tissue Engineering and Regenerative Medicine articles on DeepDyve. No university library needed.
Tissue Engineering and Regenerative Medicine covers ways to repair and regenerate tissue, from stem cell therapies and stem cell-derived exosomes to wound dressings and dental regeneration. Springer Nature publishes it. It was previously published as Chojik Konghak kwa Chaesaeng Ŭihak. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Tissue Engineering and Regenerative Medicine at a glance
- Full title
- Tissue Engineering and Regenerative Medicine
- Former title
- Chojik Konghak kwa Chaesaeng Ŭihak
- Abbreviation (NLM)
- Tissue Eng Regen Med
- Publisher
- Springer Nature
- Print ISSN
- 1738-2696
- Online ISSN (eISSN)
- 2212-5469
- Current title since
- 2012
- Access model
- Hybrid (27% free to read in 2026)
Ways to access Tissue Engineering and Regenerative Medicine
27% of the articles Tissue Engineering and Regenerative Medicine published from January 1 to November 20, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 27% of Tissue Engineering and Regenerative Medicine articles published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Tissue Engineering and Regenerative Medicine. Check its journal list and whether it offers remote access.
- DeepDyve. Read Tissue Engineering and Regenerative Medicine articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Tissue Engineering and Regenerative Medicine’s 2025 Journal Impact Factor is 5.1, and its 5-year Impact Factor is 4.9.
5.1
Journal Impact Factor (2025)
4.9
5-year Impact Factor (2025)
18 days
Median time to first decision
Source: journal metrics on the Tissue Engineering and Regenerative Medicine homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Tissue Engineering and Regenerative Medicine research worth reading
Published January to March 2026. Summaries describe what the authors report.
-
Polydeoxyribonucleotide (PDRN) in Dentistry: Narrative Review for Mechanisms and Emerging Clinical Applications
The authors review polydeoxyribonucleotide in dentistry, reporting evidence that it enhances bone formation with graft scaffolds and helps in temporomandibular joint disorders and peri-implantitis, while noting that most findings come from preclinical or small clinical studies.
Ku et al. · Tissue Engineering and Regenerative Medicine, published online January 17, 2026 · DOI 10.1007/s13770-025-00776-z
-
Therapeutic Efficacy of Mesenchymal Stem Cells (MSCs) on Alzheimer’s Disease: Review of Clinical Results
Reviewing 17 clinical trials of mesenchymal stem cells for Alzheimer’s disease, the authors report that the therapy appears feasible and generally safe, but that efficacy is unproven, with two of five outcome reports showing meaningful improvement.
Kim et al. · Tissue Engineering and Regenerative Medicine, published online January 14, 2026 · DOI 10.1007/s13770-025-00782-1
-
Liraglutide Promoted Osteogenic Differentiation of Dental Pulp Stem Cells via H3K18 Lactylation-Dependent DSPP Activation
The authors report that liraglutide enhanced proliferation and osteogenic differentiation of dental pulp stem cells by raising H3K18 histone lactylation at the DSPP gene promoter, activating its transcription, a pathway they propose for periodontal regeneration.
Li et al. · Tissue Engineering and Regenerative Medicine, published online March 18, 2026 · DOI 10.1007/s13770-026-00801-9
-
Therapeutic Effects of N-Acetylcysteine-Primed, Iron Oxide Nanoparticle-Enhanced Mesenchymal Stem Cell Exosomes in Ototoxicity Hearing Loss
In models of kanamycin-induced hearing loss, the authors report that exosomes from N-acetylcysteine-primed, nanoparticle-labeled tonsil mesenchymal stem cells better protected cochlear hair cells, improved hearing thresholds in mice and reduced inflammatory cytokines.
Batsaikhan et al. · Tissue Engineering and Regenerative Medicine, published online February 12, 2026 · DOI 10.1007/s13770-025-00784-z
-
Bacteriophage Cocktail in Hydrogel Dressing Modulates Macrophage Responses and Induces Skin Cell Migration
The authors report that phages in an alginate hydrogel dressing stayed active against their bacterial hosts, stimulated inflammatory mediators in resting macrophages but reduced them in activated ones, and that fibroblast migration correlated with macrophage TNF-α and IL-10 release.
Wu et al. · Tissue Engineering and Regenerative Medicine, published online January 10, 2026 · DOI 10.1007/s13770-025-00786-x
See every Tissue Engineering and Regenerative Medicine article on DeepDyve
Related journals
Questions about Tissue Engineering and Regenerative Medicine
How can I read Tissue Engineering and Regenerative Medicine articles without a subscription?
27% of Tissue Engineering and Regenerative Medicine articles published from January 1 to November 20, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Tissue Engineering and Regenerative Medicine articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Tissue Engineering and Regenerative Medicine?
Tissue Engineering and Regenerative Medicine’s NLM (PubMed) abbreviation is Tissue Eng Regen Med.
What is the ISSN of Tissue Engineering and Regenerative Medicine?
The print ISSN is 1738-2696 and the online ISSN is 2212-5469.
What is the impact factor of Tissue Engineering and Regenerative Medicine?
Tissue Engineering and Regenerative Medicine’s Journal Impact Factor is 5.1 (2025), and its 5-year Impact Factor is 4.9, according to Springer Nature’s published metrics.
Is Tissue Engineering and Regenerative Medicine open access?
Tissue Engineering and Regenerative Medicine is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 20, 2026, 20 of 74 Tissue Engineering and Regenerative Medicine articles (27%) carry a Creative Commons license, per Crossref.
Tissue Engineering and Regenerative Medicine articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.
Start reading Tissue Engineering and Regenerative Medicine today
One month free, then less than $2 a day. Tissue Engineering and Regenerative Medicine, plus millions of articles from thousands of journals.





